Genstruct Closes $6.5 Million Financing Round | GenomeWeb

NEW YORK, Sept. 8 (GenomeWeb News) - Genstruct, a biological mechanism discovery company, said today that it has raised $6.5 million in a round of Series A financing.

Proceeds of the financing, the Cambridge, Mass.-based company said, will be used to expand its technical and business teams, build intellectual property around the company's enabling technology, and conduct internal discovery programs.

The financing was led by A. M. Pappas and Associates, which has placed managing partner Art Pappas on Genstruct's board, and Flagship Ventures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.